Skip to the page

Data / Drug companies / Recombinant Human Growth Hormone

Recombinant Human Growth Hormone drugs: 8 drugs from 14 companies in the FDA NDC directory

Recombinant Human Growth Hormone is an FDA established pharmacologic class. The FDA National Drug Code Directory lists 44 products in this class from 14 companies, covering 8 drugs by generic name. The main marketing category is biologics (BLA), and the newest product started marketing on September 21, 2026.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

  • 14Companies
  • 44Products
  • 8Drugs by generic name

Drugs in the Recombinant Human Growth Hormone class

Ranked by number of companies that list the drug.

DrugProducts hereCompanies listing it
Somatropin66
Human growth hormone, hypophysis suis, hepar suis22
Lonapegsomatropin-tcgd141
Somatrogon-ghla21
Glandula suprarenalis suis, thyroidinum (bovine), hgh11
Human growth hormone11
Human growth hormone, pituitaria glandula, hepar suis11
Multi-potency growth hormone drops11

Companies with the most products in this class

CompanyProductsMain dosage formsMain marketing categoryNewest product started
Ascendis Pharma Endocrinology, Inc.14injection, powder, lyophilized, for solutionBiologics (BLA)July 25, 2025
Nutritional Specialties, Inc.5liquid; sprayUnapproved homeopathic productsSeptember 25, 2024
Liddell Laboratories, Inc.4sprayUnapproved homeopathic productsJanuary 31, 2025
Novo Nordisk4injection, solutionBiologics (BLA)March 30, 2009
Energique, Inc.3liquidUnapproved homeopathic productsSeptember 21, 2026
Deseret Biologicals, Inc.2liquid; tabletUnapproved homeopathic productsFebruary 10, 2022
Pfizer Laboratories Div Pfizer Inc2injection, solutionBiologics (BLA)July 31, 2023
ProBLEN2spray; liquidUnapproved homeopathic productsMay 9, 2017
Professional Complementary Health Formulas2liquidUnapproved homeopathic productsAugust 15, 1984
Sandoz Inc2injection, solutionBiologics (BLA)May 30, 2006
Dna Labs, Inc.1solutionUnapproved homeopathic productsJanuary 1, 1990
Guangzhou Renuma Medical Systems Co., Ltd1liquidUnapproved homeopathic productsOctober 31, 2017
Natural Life Foods Corporation DBA Xygenyx1gelUnapproved homeopathic productsSeptember 18, 2019
Oxylife Nutritional Supplements Inc1sprayUnapproved homeopathic productsJuly 14, 2014

Dosage forms

Dosage formProductsShare
Injection, powder, lyophilized, for solution1431.8%
Liquid1227.3%
Injection, solution818.2%
Spray715.9%
Tablet12.3%
Solution12.3%
Gel12.3%

Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.